Jaguar Health (NASDAQ:JAGX) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of Jaguar Health (NASDAQ:JAGX) in a research note issued to investors on Friday morning. The firm issued a sell rating on the biotechnology company’s stock.

Jaguar Health Stock Down 7.1 %

Shares of Jaguar Health stock opened at $5.00 on Friday. Jaguar Health has a 1 year low of $4.90 and a 1 year high of $540.00. The company has a debt-to-equity ratio of 1.65, a quick ratio of 1.36 and a current ratio of 1.84. The business has a 50-day moving average of $16.51 and a two-hundred day moving average of $23.19.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Jaguar Health stock. Virtu Financial LLC acquired a new position in shares of Jaguar Health, Inc. (NASDAQ:JAGX) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 25,591 shares of the biotechnology company’s stock, valued at approximately $35,000. Virtu Financial LLC owned 0.22% of Jaguar Health as of its most recent SEC filing. 12.04% of the stock is owned by institutional investors.

About Jaguar Health

Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.